ARCHIVES

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

Two More CHOPs Funded By NCI

March 6, 1981

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996